Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Disease area: Pulmonary vascular diseases, Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Chalmers, A. Singanayagam, C. Scally, A. Hill (Edinburgh, Perth, United Kingdom). D-dimer is an independent marker predicting severity in community acquired pneumonia. Eur Respir J 2008; 32: Suppl. 52, 2208

Member's Comments

No comment yet.

Related content which might interest you: Plasma fibrinogen concentration is an independent marker of severity in patients with community acquired pneumonia Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 The prognostic importance of plasma D-dimer levels in patients with community acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Elevated creatinine is a sensitive severity marker in community acquired pneumonia Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia. Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018 Determining the prognostic value of procalcitonin in ICU patients who developed hospital acquired pneumonia and comparing with sencitive CRP Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009 C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP) Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches Year: 2005 Incidence of ventilator associated pneumonia (VAP) and assessment of serial estimation of procalcitonin levels as a prognostic marker in cases of VAP in a tertiary centre in India Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia Source: Annual Congress 2011 - Early diagnosis in primary care Year: 2011 I-ROAD could be efficient in predicting severity of community acquired pneumonia (CAP) or healthcare-associated-pneumonia(HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 COPD is an independent risk factor for mortality in community acquired pneumonia Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Comparison of four systems for assessing severity of community acquired pneumonia Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Comparison of pneumonia severity scoring methods in identification of severe community acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 The influence of CRB-65 and some clinical and epidemiological factors over approach to community acquired pneumonia Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 The best coagulation marker for prediction of COVID-19 pneumonia progression. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Severity, risk of progression or thrombosis – what does the D-dimer really reflect in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 Biomarkers and community acquired pneumonia (CAP) severity Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011